Hepatitis C screening in isfahan drop in centers: An experience description

Journal of Isfahan Medical School

Volumn 28, Issue SPEC. ISSUE, 2011, Pages

  Meshkati, Marjan ^a   Ataei, Behrooz ^a   Nokhaodian, Zari ^a   Yaran, Majid ^a   Babak, Anahita ^a   Zadeh, Mohammad Reza Asgarian ^b   Farshad, Marzieh ^b   Adibi, Peyman ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan Welfare Organization   (Iran)

Author keywords

Drop in center; Hepatitis C screeing; Intravenuos drug abuse

Indexed keywords

METHADONE;

ACTION RESEARCH; ARTICLE; HEPATITIS C; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; METHADONE TREATMENT;

EID: 82255169335     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3(2): 41-4.
2. El Saadany S, Coyle D, Giulivi A, Afzal M. Economic burden of hepatitis C in Canada and the potential impact of prevention. Results from a disease model. Eur J Health Econ 2005; 6(2): 159-65.
3. Mandell GL, Bennett JE, Dolin P. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Chirchill Livingstone; 2010.
4. Farzanegan H. The prevalence of HBs Ag, HBs Ab and HBs Ab in Healthy blood donor and high risk group in Iran. Sang 1979; 173-82.
5. Mirahmadizadeh AR, Kadivar MR, Hemmati AR, Javadi A. Infection with HIV and hepatitis C and B viruses among injecting drug users in Shiraz, Southern Iran. International Conference on AIDS 2004; 15(11): 16.
6. Kuo I, ul-Hasan S, Galai N, Thomas DL, Zafar T, Ahmed MA et al. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm Reduct J 2006; 3:26.
7. Khamisipour GR, Tahmasebi R. Prevalence of HIV, HBV, HCV, and syphilis infection in high risk groups of Bushehr Province, 1999. Iranian Shouth Medicine Journal 2000; 3: 53-9.
8. Mohtasham AZ, Rezvani M, Jafari SR, Jafari SA. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. East Mediterr Health J 2007; 13(2): 250-6.
9. Mir-Nasseri MM, Poustchi H, Nasseri-Moghadam S, Nouraie SM, Tahaghoghi S, Afshar P. HCV in intravenous drug users. Govaresh 2005; 2: 80-6.
10. Razzaghi EM, Rahimi-movaghar A, Hosseini M, Mardani S. Chatterijee A. Rapid situation assessment of drug abuse in Iran, Tehran. Tehran: Iranian Walfare Organization and UNDCP; 1999.